Navigation Links
Michigan Growth Capital Symposium Unveils Robust Line Up of Presenting Companies for 30th Anniversary Event
Date:5/2/2011

ANN ARBOR, Mich., May 2, 2011 /PRNewswire/ -- Anticipating record attendance among the investment community at the upcoming Michigan Growth Capital Symposium, taking place May 10-11 at the Marriott Resort in Ypsilanti, Mich., event organizers today unveiled the complete list of companies that will vie for funding at this year's event. The 41 presenting companies symbolize the "Best of the Midwest" businesses and were selected from a competitive pool of 85 applications.  During the past 10 years, more than 300 companies have presented at the Symposium. Seventy-one percent have raised capital totaling $1.7 billion in investment dollars and of those, 20 percent have gone on to realize successful exits.

This year's roster represents the Midwest industries that have emerged as having the greatest growth potential, including information technology, clean technology, medical devices and life science. Among them are seven University spinouts, including InPore Technologies and Life Magnetics, as well as companies traveling from as far as Kentucky and Massachusetts to participate. This year will mark an encore appearance for several companies, most notably Esperion Therapeutics. The Plymouth, Mich.-based biotech company presented in 1998, was bought out by Pfizer in 2004 for $1.3 billion and after divesting in 2008, is back to present at the Symposium in 2011.  

Nextronex Energy Systems, a Toledo, OH-based solar component manufacturing company, will be presenting at the Symposium for the first time, in the highly anticipated clean tech track. Commenting on the value of the event, CEO Bruce Larsen said: "Many of the companies that have presented at The Michigan Growth Capital Symposium have gone on to great success, which makes me confident that it is going to be a great forum for Nextronex. It has the clout to attract the influential Midwest and coastal VCs that we're eager to pitch, but it is still intimate enough that we'll be able to make one-on-one connections and cultivate relationships with them."

Hosted by the Ross School of Business' Zell Lurie Institute at the University of Michigan with support from the Michigan Venture Capital Association,  The Michigan Growth Capital Symposium, has become the gold standard for start-up investment in the Midwest. It serves as a conduit for introducing regional and national investors to promising startups and established, high growth organizations seeking funding. This year a new format has been expanded to include companies seeking angel and seed funding, as well as companies seeking follow-on rounds of funding up to $20 million.

"There is no question that the quality of presenting startups has improved, which is a testament to the fact that we are part of something major happening in the Midwest," said David Brophy, founder of the Symposium and professor of finance at University of Michigan Ross School of Business. "The light bulb has gone on. Large research universities are embracing technology transfer, talent is staying local and investors are doing deals here. I'm confident the next Michigan success story, akin to HealthMedia or Accuri, could be among this year's crop of presenting companies."

The complete list of presenting companies is now available at www.michigangcs.com.  Registration will remain open until May 9 at the same site.  To follow and contribute to conversations ahead of and during the event, track and use #MGCS on Twitter.

About the Michigan Growth Capital Symposium (MGCS)

MGCS is the original university-based venture fair, which was first held in 1979. This nationally attended two-day event provides an opportunity for financiers to connect with up-and-coming Midwest businesses and learn about emerging technologies. The Symposium offers the opportunity to build relationships with an unparalleled business network of distinguished private equity industry leaders and entrepreneurial business professionals. Entering its 30th year, MGCS continues to draw top investors from coast to coast. MGCS is presented by the Center for Venture Capital & Private Equity Finance at the Ross School of Business at the University of Michigan with support from the Michigan Venture Capital Association.


'/>"/>
SOURCE Michigan Growth Capital Symposium
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Michigan Home Medical Equipment Providers Back New Congressional Bill to Repeal Flawed Medicare Bidding Program
2. Detroit Medical Center Becomes First in Southeast Michigan to Study an Implantable Device, Designed to Reduce Patient Time to the ER and Improve Survival Rates From Heart Attack in High-Risk Patients
3. Detroit Medical Center Is First in Michigan to Offer New Breakthrough Technology for Correcting Irregular Heartbeat
4. FDA: Michigan Heart-Lung Bypass Machine Manufacturer Enters Into Consent Decree
5. Zell Lurie Institute Awards $106,300 to University of Michigan Students Through the Michigan Business Challenge and Dare to Dream Startup Grant Program
6. Michigan Pre-Seed Capital Fund Reports Investments Totaling $2.5 Million in 2010
7. SurgiCount Medical Announces the Successful Implementation of the Safety-Sponge® System at the University of Michigan Health System
8. Exciting Healthcare News for Women of Mid Michigan
9. Southeastern Michigan Gets First Ever FDA Approved Device That Destroys Fat Cells ... Without Surgery
10. Business Accelerator Network for Southeast Michigan Announces Accelerate Michigan Innovation Competition
11. Michigan Home Medical Providers Call on Congress to Preserve Homecare as an Option for Seniors and People With Disabilities Under Medicare
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... Belgium , June 24, 2016 /PRNewswire/ ... announced the appointment of Dr. Edward Futcher ... a Non-Executive Director, effective June 23, 2016.Dr. Futcher ... and Nominations and Governance Committees.  As a non-executive ... provide independent expertise and strategic counsel to VolitionRx ...
(Date:6/23/2016)... Research and Markets has announced the ... to 2022" report to their offering. ... patients with kidney failure, it replaces the function of kidneys ... blood and thus the treatment helps to keep the patient ... Increasing number of ESRD patients & substantial ...
(Date:6/23/2016)... , June 23, 2016  In a startling report released today, ... their residents by lacking a comprehensive, proven plan to eliminate prescription ... definitive ranking of how states are tackling the worst drug crisis ... four states – Kentucky , New ... Vermont . Of the 28 failing states, three – ...
Breaking Medicine Technology:
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... Conference and Scientific Sessions in Dallas that it will receive two significant new ... the grants came as PHA marked its 25th anniversary by recognizing patients, medical ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, ... and the Road To Recovery® program to drive cancer patients to and from their ... to ensure the highest quality of life and ongoing independence. Getting to and ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... today at the Clinical Decision Making in Emergency Medicine conference in Ponte Vedra ... authored journal articles published in Emergency Medicine Practice and Pediatric Emergency ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... feeding the Frederick area economy by obtaining investment capital for emerging technology companies. ... 2½ years that have already resulted in more than a million dollars of ...
(Date:6/24/2016)... Gaithersburg, MD (PRWEB) , ... June 24, 2016 ... ... and protocols for human induced pluripotent stem (iPS) cells and other difficult to ... PluriQ™ G9™ Cloning Medium. The PluriQ™ G9™ Gene Editing System is ...
Breaking Medicine News(10 mins):